Alzamend Neuro Dividends and Buybacks
Dividend criteria checks 0/6
Alzamend Neuro does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-36.9%
Buyback Yield
| Total Shareholder Yield | -36.9% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is Alzamend Neuro (NASDAQ:ALZN) In A Good Position To Deliver On Growth Plans?
Jul 26
Is Alzamend Neuro (NASDAQ:ALZN) In A Good Position To Deliver On Growth Plans?
Mar 20We're Not Very Worried About Alzamend Neuro's (NASDAQ:ALZN) Cash Burn Rate
Oct 14Alzamend stock falls amid start of AL001 dosing in healthy people in Alzheimer's trial
Oct 05Alzamend seeks FDA nod for early-stage trial of its therapy for Alzheimer’s type dementia
Sep 29Alzamend Neuro receives positive pre-IND response from FDA for AL001
Jul 18Alzamend: Biotech To Watch With 2 Drugs Targeting Multi-Billion Dollar Alzheimer's Market
Dec 18Alzamend Neuro closes $14.4M IPO
Jun 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ALZN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ALZN's dividend payments have been increasing.
Dividend Yield vs Market
| Alzamend Neuro Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ALZN) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.5% |
| Industry Average (Biotechs) | 2.4% |
| Analyst forecast (ALZN) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate ALZN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ALZN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate ALZN's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ALZN has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 06:25 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alzamend Neuro, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |